Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — H1 2016 Earnings Presentation
11 slides from Novonesis A/s Class B's earnings presentation, Aug 10, 2016
Slide 1: Conference call 1H 2016
Conference call 1H 2016 August 10, 2016
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "be
Slide 3: 1H 2016 Summary
1H 2016 Summary Sales and organic growth Q2 sales increased but were lower than expected 1H 2014 – 1H 2016 DKKm 12% 7.500 • 3% organic sales growth and flat sales in DKK in 1H 2016. Growth driven by Household Care, Food & Beverages and Technical 10% 8% 7.000 & Pharma 8% 6% 5% 6.500 • BioAg and Bioe
Slide 4: Household Care & Technical
Household Care & Technical +4% / +3% Organic growth / DKK growth Household Care • Satisfactory sales growth in HHC supported by demand for liquids 2.330 2.265 in Asia Pacific and premium detergents in North America. Europe and Latin American are both slightly positive for the first half of the year
Slide 5: Agriculture & Bioenergy
Agriculture & Bioenergy Organic growth / DKK growth Bioenergy • Sales contracted in the first half of the year as ethanol producers continued to optimize their production economy and enzyme spend. Tough price competition; producer margins remained low -6% / -7% +1% / -6% • Trialing of Avantec® Amp
Slide 6: The upcoming launch of the new corn inoculant
The upcoming launch of the new corn inoculant Our current business in BioAg New corn inoculant • Slightly less than half of our Ag/Feed • First ever inoculant for corn applied by a seed segment, soy being the primary crop company (upstream) • Sales growth in DKK is currently impacted • Launch plan
Slide 7: Food & Beverages
Food & Beverages Organic growth / DKK growth Baking +3% / +1% • Baking still driving growth, though more modestly than in recent years and mainly in Europe and emerging markets Starch • Solid growth in starch driven by increased penetration mainly in 1.856 1.846 Europe Food & Nutrition • Food & Nu
Slide 8: Research & Innovation update
Research & Innovation update Household Care Amplify Prime® best-in-class liquid amylase • In-depth cleaning at low temperatures • Best starch removal technology optimized for short wash cycles Progress Uno® protease for tough conditions • Exceptionally high performing protease that delivers consiste
Slide 9: Research & Innovation update: DONG REnescience plant supply
Research & Innovation update Novozymes to supply DONG’s new REnescience® plant in Northwich, U.K. – new biological waste-sorting technology QUARTERLY 9 RESULTS • NOVOZYMES OVERVIEW • STRATEGY • SEGMENTAL OVERVIEW • SUSTAINABILITY • FINANCIAL REVIEW
Slide 10: Financial performance & outlook
Financial performance & outlook 1H 2016: Net profit in line with expectations Key Realized 2016 outlook financials 1H 2016 August 10 • Gross margin on par with first half last year, as productivity improvements offset the one-time reorganization cost incurred in Q1 Sales growth, org. 3% 2-4% • Adju
Slide 11: Novozymes – Rethink Tomorrow
x novozymes’ Rethink Tomorrow